Framework for prioritizing head and neck surgery during the COVID-19 pandemic.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32298036.
- Also identified by DOI 10.1002/hed.26184 and PMC identifier 7262168.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The COVID-19 pandemic has placed an extraordinary demand on the United States health care system. Many institutions have canceled elective and non-urgent procedures to conserve resources and limit exposure. While operational definitions of elective and urgent categories exist, there is a degree of surgeon judgment in designation. In the present commentary, we provide a framework for prioritizing head and neck surgery during the pandemic. Unique considerations for the head and neck patient are examined including risk to the oncology patient, outcomes following delay in head and neck cancer therapy, and risk of transmission during otolaryngologic surgery. Our case prioritization criteria consist of four categories: urgent-proceed with surgery, less urgent-consider postpone > 30 days, less urgent-consider postpone 30 to 90 days, and case-by-case basis. Finally, we discuss our preoperative clinical pathway for transmission mitigation including defining low-risk and high-risk surgery for transmission and role of preoperative COVID-19 testing.
Medical subject headings
- Coronavirus Infections
- Head and Neck Neoplasms
- Otorhinolaryngologic Surgical Procedures
- Pandemics
- Pneumonia, Viral
- Time-to-Treatment